Skip to main content
Log in

Ruolo delle indagini diagnostiche di medicina nucleare nelle neoplasie neuroendocrine

  • NET
  • Published:
L'Endocrinologo Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Bibliografia

  1. Carideo L, Prosperi D, Panzuto F et al. (2019) Role of combined [68Ga]Ga-DOTA-SST analogues and [18F]FDG PET/CT in the management of GEP-NENs: a systematic review. J Clin Med 8(7):1032

    Article  CAS  Google Scholar 

  2. Calabrò D, Argalia G, Ambrosini V (2020) Role of PET/CT and therapy management of pancreatic neuroendocrine tumors. Diagnostics (Basel) 10(12):1059

    Article  Google Scholar 

  3. Barrio M, Czernin J, Fanti S et al. (2017) The impact of somatostatin receptor-directed PET/TC on the management of patients with neuroendocrine tumor: a systematic review and meta-analysis. J Nucl Med 58(5):756–761

    Article  Google Scholar 

  4. Bodei L, Mueller-Brand J, Baum RP et al. (2013) The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours. Eur J Nucl Med Mol Imaging 40(5):800–816

    Article  CAS  Google Scholar 

  5. Hicks RJ, Kwekkeboom DJ, Krenning E et al. for the Antibes Consensus Conference participants (2017) ENETS consensus guidelines for the standards of care in neuroendocrine neoplasia: peptide receptor radionuclide therapy with radiolabeled somatostatin analogues. Neuroendocrinology 105(3):295–309

    Article  CAS  Google Scholar 

  6. AIOM in condivisione con It.a.net. Linee Guida Neoplasie Neuroendocrine (2020). https://www.aiom.it/wp-content/uploads/2020/10/2020_LG_AIOM_Neuroendocrini.pdf. Accessed on May 2021

  7. Evangelista L, Ravelli I, Bignotto A et al. (2020) Ga-68 DOTA-peptides and F-18 FDG PET/CT in patients with neuroendocrine tumor: a review. Clin Imaging 67:113–116

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marco Gallo.

Ethics declarations

Conflitto di interesse

Maura Rossi ha dichiarato di aver ricevuto dei grant da Novartis, AAA e IPSEN (spese di viaggio e iscrizione a congressi ed emolumenti per partecipazione a panel di esperti). Elena Pomposelli e Marco Gallo dichiarano di non avere conflitti di interesse.

Consenso informato

Lo studio presentato in questo articolo non ha richiesto sperimentazione umana.

Studi sugli animali

Gli autori di questo articolo non hanno eseguito studi sugli animali.

Additional information

Nota della casa editrice

Springer Nature rimane neutrale in riguardo alle rivendicazioni giurisdizionali nelle mappe pubblicate e nelle affiliazioni istituzionali.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pomposelli, E., Rossi, M. & Gallo, M. Ruolo delle indagini diagnostiche di medicina nucleare nelle neoplasie neuroendocrine. L'Endocrinologo 23 (Suppl 1), 32–34 (2022). https://doi.org/10.1007/s40619-022-01097-2

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40619-022-01097-2

Navigation